IL18 and nasopharyngeal carcinoma: In vitro, administration of Ac-YVAD-CHO, a caspase-1 inhibitor into NPC cell lines was shown to significantly suppress the secretion of IL-18, indicating that IL-18 production is caspase-1 dependent [170].